Biomarkers in Alzheimer's Disease

Author: Khan Tapan

Language: English

Cover of the book Biomarkers in Alzheimer's Disease

Subjects for Biomarkers in Alzheimer's Disease:

Keywords

AÎ²1-42AD risk factorsAlzheimer's disease (AD) biomarkersAlzheimer's disease assessment scale (ADAS)amyloid beta (AÎ²)amyloid precursor protein (APP)APOE4biomarkerblood cell-based AD biomarkersbrain atrophybuccal cell-based AD biomarkersc-reactive proteinCa2+ signaling in ADcell cyclecerebrospinal fluid (CSF) biomarkerscerebrospinal fluid biomarkersclinical AD diagnosisclinical dementia rating (CDR)clinical trialsdrug efficacyeconomic impact of ADfunctional MRI (fMRI)genetic biomarkersgenetics of ADGWASIWG AD criterialipidomicslumbar puncturemagnetic resonance spectroscopy (MRS)micro arraymicro RNAmild cognitive impairment (MCI)mini-mental state examination (MMSE)multicomponent AD biomarkersneuroimaging biomarkersneuroimaging in ADNINCDS-ADRDAnon-AD dementiaNT-proBNPnuclear magnetic resonance imaging (MRI)ocular AD biomarkerspancreatic polypeptideperipheral biomarkersperipheral cells in ADperipheral fluid biomarkerspharmacogenomicsphosphorylated tau-181PKC in ADplasma AÎ² AD biomarkerpositron emission tomography (PET)preclinical ADproteomicsPSEN1PSEN2risk factors of ADsingle-photon emission computed tomography (SPECT)skin fibroblast-based AD biomarkersSOLR1total tau (t-tau)transcriptomicurinary AD7c-NTP[11C]-Pittsburgh compound B[18F]-fluoro-2-deoxy-d-glucose (18FDG)

80.59 €

In Print (Delivery period: 14 days).

Add to cart

the book of Khan Tapan

Publication date: 08-2016
276 p. · 19x23.3 cm · Hardback

Description
/li>
Contents
/li>
Biography
/li>
Comment
/li>

Biomarkers in Alzheimer?s Disease provides a comprehensive overview of all modalities of Alzheimer?s disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer?s disease and technological advancement of biomarkers techniques.

The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer?s disease, and for differential diagnosis of Alzheimer?s disease with other non-Alzheimer?s dementia.

Chapter 1: Introduction to Alzheimer’s Disease Biomarkers

Chapter 2: Clinical Diagnosis of Alzheimer’s Disease

Chapter 3: Neuroimaging Biomarkers in Alzheimer’s Disease

Chapter 4: Genetic Biomarkers in Alzheimer’s Disease

Chapter 5: Alzheimer’s Disease Cerebrospinal Fluid (CSF) Biomarkers

Chapter 6: Peripheral Fluid-Based Biomarkers of Alzheimer’s Disease

Chapter 7: Cell-Based Alzheimer’s Disease Biomarkers

Dr. Khan is an Associate Professor at the Blanchette Rockefeller Neurosciences Institute (BRNI). BRNI is operated in alliance with West Virginia University in Morgantown, USA. Dr. Khan has more than a decade of research experience in the Alzheimer’s disease research area. He is an Associate Editor for Journal of Alzheimer’s Disease and is a regular reviewer for many journals including: European Journal of Pharmaceutical Sciences, Bioorganic & Medicinal Chemistry, CNS & Neurological Disorders-Drug Targets, Neuropeptides, Journal of Biomolecular Structure & Dynamics, Stem Cell Research & Therapy.

Presents a comprehensive overview detailing all modalities of Alzheimer’s disease biomarkers
Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer’s Disease
Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer’s disease and the technological advancement of biomarkers techniques

Biomarkers in Alzheimer's Disease

Author: Khan Tapan

Subjects for Biomarkers in Alzheimer's Disease:

Keywords

Description

Contents

Biography

Comment

These books may interest you